Reddy Cancer Treatment Center Malone, NY - 12953

Reddy Cancer Treatment Center is categorized under Radiation Laboratories in Malone, NY and active since 1997.

Reddy Cancer Treatment Center was established in 1997, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Radiation Laboratories business, which does work in the B2B market, and is classified as a Radiation Laboratories, under code number 6223100 by the NAICS.

If you are seeking more information, feel free to contact Amy O'Connor, Manager at the company’s single location by writing to 23 4th St # 2, Malone, New York NY 12953 or by phoning (518) 481-2880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Reddy Cancer Treatment Center
Contact Person: Amy O'Connor, Manager
Address: 23 4th St # 2, Malone, New York 12953
Phone Number: (518) 481-2880
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Radiation Laboratories
SIC Code: 8734
NAICS Code: 6223100
Share This Business:

Reddy Cancer Treatment Center was started in 1997 to provide professional Radiation Laboratories under the SIC code 8734 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Amy O'Connor, Manager for inquiries that concern Reddy Cancer Treatment Center by calling the company number (518) 481-2880, as your correspondence is most welcome. Additionally, the physical location of the single location of Reddy Cancer Treatment Center can be found at the coordinates 44.857249,-74.289893 as well as the street address 23 4th St # 2 in Malone, New York 12953.

For its online presence, you may visit Reddy Cancer Treatment Center’s website at and engage with its social media outlets through on Twitter and on Facebook.